DJIA 18,177.63 136.09 0.75%
NASDAQ 5,110.00 77.25 1.53%
S&P 500 2,123.48 19.28 0.92%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

160.53 1.52 (0.96%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $160.53 0.96%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $159.96
Previous Close $159.01
Daily Range $159.28 - $161.00
52-Week Range $114.72 - $173.60
Market Cap $122.1B
P/E Ratio 21.46
Dividend (Yield) $3.16 (2.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,649,304
Average Daily Volume 3,298,342
Current FY EPS $9.56




Drug Makers

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

CNBC's Stock Pops & Drops From May 26

Amgen, AstraZeneca End Development Pact; Shares Sink

Amgen's Cholesterol Fighting Drug Receives EU Approval

A Review Of Amgen's AMG 334

Actavis to Continue Selling Namenda IR under Court Ruling - Analyst Blog

Actavis to Continue Selling Namenda IR under Court Ruling - Analyst Blog

Health Care Stocks For A Dividend Growth Portfolio - Part 2

VUG, ORCL, AMGN, ACT: ETF Inflow Alert

Morgan Stanley Found This 'Unexpected Negative' At Amgen

AstraZeneca, Amgen End Psoriasis Drug Brodalumab Deal - Analyst Blog

See More AMGN News...

AMGN's Top Competitors

AMGN $160.53 (0.96%)
Current stock: AMGN
GILD $112.45 (2.44%)
Current stock: GILD
CELG $116.09 (1.42%)
Current stock: CELG
$0.00 (0.00%)
Current stock: